However, during the course of this study we realized that in mesenchymal-type cancer cells from pancreas and breast RAC1B-induced autocrine TGFβ can stimulate ECAD expression and block cell motility through a pathway that involves SMAD3 and presumably SMAD3-dependent induction of miR-200. Here, SMAD3 is linked to cancer.